Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography

被引:15
|
作者
Elhendy, A
Schinkel, AFL
van Domburg, RT
Bax, JJ
Valkema, R
Poldermans, D
机构
[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[2] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands
[3] Leiden Univ Hosp, Leiden, Netherlands
[4] Univ Nebraska, Div Cardiol, Dept Internal Med, Omaha, NE USA
[5] Univ Nebraska, Med Ctr, Omaha, NE USA
关键词
prognosis; stress testing; myocardial revascularization; myocardial perfusion imaging; technetium 99m tetrofosmin;
D O I
10.1016/S1071-3581(03)00651-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The aim of this study was to assess the incremental prognostic value of stress technetium 99m tetrofosmin imaging after myocardial revascularization. Methods and Results. We studied 381 patients (aged 60 ± 10 years, 270 men), 4.5 ± 3.2 years after myocardial revascularization (coronary artery bypass grafting in 201 patients and percutaneous coronary intervention in 180 patients), who underwent exercise or dobutamine stress tetrofosmin single photon emission computed tomography. Events during a mean follow-up period of 3.5 ± 1.4 years were cardiac death in 22 patients, nonfatal myocardial infarction in 11 patients (33 hard cardiac events), and late revascularization in 50 patients. There was no incidence of hard cardiac events in the 100 patients with normal perfusion. Hard cardiac events occurred in 19% of patients with reversible perfusion abnormalities and in 4% of patients without them (P < .01). The incidence of hard cardiac events was similar in patients with and without angina before stress testing (17/197 [8.6%] vs 16/184 [8.7%]). In a multivariate analysis model, predictors of cardiac death were stress rate pressure product and abnormal perfusion. Reversible perfusion abnormalities were independently associated with the composite endpoints of cardiac death, nonfatal myocardial infarction, and late revascularization. In an incremental multivariate analysis model, an abnormal scan was additive to clinical data in the prediction of hard cardiac events (model X2 = 17 vs 11, P < .01). Conclusion. Stress Tc-99m tetrofosmin myocardial perfusion imaging provides independent prognostic information for the prediction of cardiac events after myocardial revascularization. Symptoms are not predictive of outcome, and therefore asymptomatic patients should not be deferred from stress testing. A normal study identifies a very low-risk population in whom no further intervention is required.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 50 条
  • [21] Tc-99m-N-MPO: Novel cationic Tc-99m radiotracer for myocardial perfusion imaging
    Kim, Young-Seung
    Wang, Jianjun
    Broisat, Alexis
    Glover, David K.
    Liu, Shuang
    JOURNAL OF NUCLEAR CARDIOLOGY, 2008, 15 (04) : 535 - 546
  • [22] REDUCED VARIABILITY OF INTERPRETATION AND IMPROVED IMAGE QUALITY WITH A TC-99M MYOCARDIAL PERFUSION AGENT - COMPARISON OF TL-201 AND TC-99M-LABELED TETROFOSMIN
    HENDEL, RC
    PARKER, MA
    WACKERS, FJT
    RIGO, P
    LAHIRI, A
    ZARET, BL
    JOURNAL OF NUCLEAR CARDIOLOGY, 1994, 1 (06) : 509 - 514
  • [23] Tc-99m sestamibi myocardial perfusion imaging after undisclosed I-131 therapy
    Andrew F. Robertson
    Dale L. Bailey
    Paul J. Roach
    Melissa A. Shields
    Journal of Nuclear Cardiology, 2006, 13 : 722 - 724
  • [24] Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: Impact of scintigraphic extent of coronary artery disease
    Abdou Elhendy
    Arend F. L. Schinkel
    Ron T. van Domburg
    Jeroen J. Bax
    Roelf Valkema
    Don Poldermans
    Journal of Nuclear Cardiology, 2004, 11 : 704 - 709
  • [25] Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: Impact of scintigraphic extent of coronary artery disease
    Elhendy, A
    Schinkel, AFL
    van Domburg, RT
    Bax, JJ
    Valkema, R
    Poldermans, D
    JOURNAL OF NUCLEAR CARDIOLOGY, 2004, 11 (06) : 704 - 709
  • [26] Role of Tc-99m sestamibi myocardial perfusion imaging in identifying multiple myeloma
    Ravishankar V. Kalaga
    Vinod Kudagi
    Gary V. Heller
    Journal of Nuclear Cardiology, 2009, 16 : 835 - 837
  • [27] TC-99M TEBOROXIME SCINTIGRAPHY - CLINICAL-EXPERIENCE IN PATIENTS REFERRED FOR MYOCARDIAL PERFUSION EVALUATION
    BONTEMPS, L
    GERONICOLATRAPALI, X
    SAYEGH, Y
    DELMAS, O
    ITTI, R
    ANDREFOUET, X
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1991, 18 (09): : 732 - 739
  • [28] Incidental Detection of a Benign Thymoma on Tc-99m MIBI Myocardial Perfusion Study
    Aydin, Funda
    Budak, Evrim Surer
    Dertsiz, Levent
    Belgi, Aytul
    Arslan, Gokhan
    Gungor, Firat
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2011, 20 (02) : 73 - 74
  • [29] EXERCISE TC-99M SESTAMIBI TOMOGRAPHY FOR CARDIAC RISK STRATIFICATION OF PATIENTS WITH STABLE CHEST PAIN
    STRATMANN, HG
    WILLIAMS, GA
    WITTRY, MD
    CHAITMAN, BR
    MILLER, DD
    CIRCULATION, 1994, 89 (02) : 615 - 622
  • [30] The Value of Myocardial Perfusion Imaging with Tc-99m MIBI for the Prediction of Perfusion Improvement after Percutaneous Transluminal Coronary Angioplasty
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Mohagheghi, Abbas
    Assadi, Majid
    Beiki, Davood
    Eftekhari, Mohammad
    Saghari, Mohsen
    Takavar, Abbas
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2010, 18 (01): : 7 - 13